Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Escalon develops picosecond laser technology:

This article was originally published in Clinica

Executive Summary

Escalon is developing ultrafast lasers for refractive eye surgery. The company, which is based in Skillman, New Jersey, recently received two patents and notice of a third from the US Trademark and Patent Office. Escalon says that the three most common eye disorders are nearsightedness, farsightedness and astigmatism. As many as 140 million people in the US use eyeglasses and/or contact lenses to correct refractive disorders.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel